Search Results - "Muffly LS"

A QUEST to improve outcomes for adults with high-risk B-ALL.

Authors: Srinagesh HK Muffly LS

Source: Blood [Blood] 2026 Jul 16; Vol. 148 (3), pp. 265-266.

Publication Type: Editorial; Comment

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE; In Process

Allogeneic Hematopoietic Cell Transplant Following Standard of Care Brexucabtagene Autoleucel (Brexu-cel) in Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): Results from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA).

Authors: Faramand RG Zhang A Roloff GW et al.

Source: Transplantation and cellular therapy [Transplant Cell Ther] 2026 Jun 27. Date of Electronic Publication: 2026 Jun 27.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALL.

Authors: Othman T Roloff GW Miller K et al.

Source: Blood advances [Blood Adv] 2026 Jun 25. Date of Electronic Publication: 2026 Jun 25.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Incidence and Risk Factors for CNS Relapse in Adult ALL after Allogeneic Hematopoietic Cell Transplantation.

Authors: Le CTK Zhang A Vyas RD et al.

Source: Blood advances [Blood Adv] 2026 Jun 24. Date of Electronic Publication: 2026 Jun 24.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL.

Authors: Srinagesh HK Gupta V Zhang A et al.

Source: Blood [Blood] 2026 Apr 23; Vol. 147 (17), pp. 2011-2017.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

A phase 1/2 study of donor-derived anti-CD33 CAR T-cell therapy (VCAR33) for relapsed/refractory AML after allogeneic HCT.

Authors: Mushtaq MU DiPersio JF Azzi J et al.

Source: Blood [Blood] 2026 Apr 23; Vol. 147 (17), pp. 1914-1927.

Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Zamtocabtagene autoleucel: dual CD20-CD19 targeting for NHL.

Authors: Srinagesh HK Muffly LS

Source: Blood advances [Blood Adv] 2026 Apr 14; Vol. 10 (7), pp. 2429-2430.

Publication Type: Editorial; Comment

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE; In Process

Dynamics of BCMA expression in patients with relapsed/refractory multiple myeloma receiving BCMA-directed CAR-T therapy.

Authors: Rana MS Fernandez-Pol S Jensen A et al.

Source: Blood cancer journal [Blood Cancer J] 2026 Apr 04; Vol. 16 (1). Date of Electronic Publication: 2026 Apr 04.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Clinical and Cytokine Features of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.

Authors: Srinagesh HK Kramer AM Baird JH et al.

Source: Blood cancer discovery [Blood Cancer Discov] 2026 Mar 04; Vol. 7 (2), pp. 225-233.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE

Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategies.

Authors: Dreyzin A Kramer AM Yates B et al.

Source: Cytotherapy [Cytotherapy] 2026 Mar; Vol. 28 (3), pp. 101990. Date of Electronic Publication: 2025 Oct 02.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566 (Electronic) Linking ISSN: 14653249 NLM ISO Abbreviation: Cytotherapy Subsets: MEDLINE

Predicting relapse in acute lymphoblastic leukemia.

Authors: Schwartz MS Muffly LS

Source: Leukemia & lymphoma [Leuk Lymphoma] 2024 Dec; Vol. 65 (13), pp. 1934-1940. Date of Electronic Publication: 2024 Aug 31.

Publication Type: Journal Article; Review

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia.

Authors: Valtis YK Lin C Nemirovsky D et al.

Source: Blood advances [Blood Adv] 2026 Jan 13; Vol. 10 (1), pp. 276-288.

Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Phase II study of novel CXCR2 agonist and Plerixafor for rapid stem cell mobilization in patients with multiple myeloma.

Authors: Sidana S Bankova AK Hosoya H et al.

Source: Blood cancer journal [Blood Cancer J] 2024 Oct 09; Vol. 14 (1), pp. 173. Date of Electronic Publication: 2024 Oct 09.

Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Travel-time barriers to specialized cancer care for adolescents and young adults with acute lymphoblastic leukemia.

Authors: Parsons HM Muffly LS Garcia A et al.

Source: JNCI cancer spectrum [JNCI Cancer Spectr] 2024 Jul 01; Vol. 8 (4).

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101721827 Publication Model: Print Cited Medium: Internet ISSN: 2515-5091 (Electronic) Linking ISSN: 25155091 NLM ISO Abbreviation: JNCI Cancer Spectr Subsets: MEDLINE

The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia.

Authors: O'Connor TE Lin C Roloff GW et al.

Source: Bone marrow transplantation [Bone Marrow Transplant] 2025 Nov; Vol. 60 (11), pp. 1465-1471. Date of Electronic Publication: 2025 Aug 23.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia.

Authors: Levis MJ Hamadani M Logan BR et al.

Source: Blood advances [Blood Adv] 2025 Oct 28; Vol. 9 (20), pp. 5123-5133.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Remission of TP53-Mutant AML After Transplantation With Trem-Cel, a CRISPR/Cas9 Gene-Edited Allograft Lacking CD33, Followed by a Donor-Derived Anti-CD33 Chimeric Antigen Receptor T (VCAR33).

Authors: Koehne G Mushtaq MU Muffly LS et al.

Source: JCO precision oncology [JCO Precis Oncol] 2025 Oct; Vol. 9, pp. e2500556. Date of Electronic Publication: 2025 Oct 23.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE; In Process

Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvement.

Authors: Muhsen IN Roloff GW Faramand R et al.

Source: Blood advances [Blood Adv] 2025 Aug 26; Vol. 9 (16), pp. 4081-4089.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma.

Authors: Sidana S Hosoya H Jensen A et al.

Source: Blood cancer journal [Blood Cancer J] 2023 Oct 13; Vol. 13 (1), pp. 158. Date of Electronic Publication: 2023 Oct 13.

Publication Type: Letter; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Real-world performance of the CALGB 10403 regimen in young adults in the United States.

Authors: DaSilva B Darwin A Zhang A et al.

Source: Blood neoplasia [Blood Neoplasia] 2025 May 12; Vol. 2 (3), pp. 100111. Date of Electronic Publication: 2025 May 12 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918841988906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3280 (Electronic) Linking ISSN: 29503280 NLM ISO Abbreviation: Blood Neoplasia Subsets: PubMed not MEDLINE